Psoriasis is a chronic autoimmune inflammatory disease that remains active for a long
period, even for life in most patients. The impact of psoriasis on health is not only limited to …

Psoriatic disease is a chronic, systemic immune‐mediated inflammatory disorder comprising
three major domains, skin, vascular and bone/joint inflammation. It is known for a long time …

For people with psoriasis, biomarkers aiding in the personalization of treatment with
biologics are needed. We examined the usefulness of several biomarkers of inflammation in …

Associations of liver, metabolic, and inflammatory biomarkers in blood with body shape are
unclear, because waist circumference (WC) and hip circumference (HC) are dependent on …

Psoriasis is an immune-mediated inflammatory disease associated with an increased risk of
cardiovascular disease (CVD). The risk of CVD increases with the severity of psoriasis, and …

However, markers of systemic inflammation were numerically lower in patients treated with
biologics and these biologics may hold the potential to reduce the risk of CVD in patients …

Background Methotrexate (MTX) is the first‐line medicine to treat psoriasis. So far, there has
been less research on protein biomarkers to predict its efficacy by the proteomic technique …

Neutrophil-derived bactericidal/permeability-increasing protein (BPI) is known for its
bactericidal activity against gram-negative bacteria and neutralization of lipopolysaccharide …

Background and Aim Psoriasis is a persistent inflammatory disorder that affects 3% of the
population and is associated with cardiovascular diseases. Therefore, this study aimed to …

Psoriasis is a chronic immune-mediated disease, linked to local and systemic inflammation
and predisposing patients to a higher risk of associated comorbidities. Cytokine levels are …